So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

Police and Crime Commissioner Joy Allen has expressed support for Government plans to seek expert advice on reclassifying ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.

County Durham and Darlington Police and Crime Commissioner (PCC) Joy Allen has welcomed Government plans to seek advice on ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...